©2019 by Pacific Northwest News & Entertainment In Collaboration with BOKI CREATIVE
 

Drug Take Back Bill Becomes Law


Oregon joined five states with a new law that requires drug manufacturers to pay for and run a statewide drug take-back program. The law, signed by Governor Kate Brown and championed by Representative Sheri Schouten, will ensure that every community in Oregon has free, convenient access to safe drug disposal. The law takes effect in September 2019 and the program must be operational by July 1, 2021.

“Unused medications are a threat to our state’s health and environment. I’m so pleased Oregonians will now have a free, convenient, safe place to dispose of unwanted drugs,” said Representative Schouten, who sponsored the bill.

Unused medications can be dangerous, especially to children, the elderly, and pets. They can lead to drug abuse, misuse and accidental poisonings. Furthermore, they can’t simply be disposed down the drain or in the trash, because they leak into our waterways and harm wildlife. Now, Oregon residents will be able to take unused drugs back to a pharmacy for safe, environmentally responsible disposal. Prepaid mail-back envelopes will also be available.

The coalition’s work built on the foundation laid by the Product Stewardship Institute (PSI), a national nonprofit, which over the past 15 years has paved the way for the passage of drug take-back laws around the country. PSI led a national effort that changed the federal Controlled Substances Act and Drug Enforcement Administration regulations to allow convenient pharmacy collections. Today, the organization coordinates state and local agencies around the country to share information and strategies, and supports drug take-back bills.

“This new law is a major victory for consumers. It is a critical strike against the prescription opioid crisis and will go a long way to protect our water quality,” said Scott Cassel, Chief Executive Officer and Founder of PSI. “It will remove a substantial financial and management burden from governments and taxpayers, placing the primary responsibility with the drug companies that put these products on the market and profit from them.”

Oregon is the sixth state to require manufacturers to fund and safely manage drug take-back, preceded by Massachusetts, Vermont, Washington, New York, and California.